Results 211 to 220 of about 220,820 (267)

Cross-national biologic treatment guidelines for FMF: a comparative analysis. [PDF]

Rheumatology (Oxford)
Kasap Cuceoglu M, Hinze T, Wittkowski H, Haslak F, Mamutova A, Oner N, Caorsi R, Bourguiba R, Elhani I, Delplanque M, El Moussaoui M, Pateras K, Sestan M, Kirijas M, Constantin T, Ducharme-Benard S, Lanchmann H, Butbul Aviel Y, Hentgen V.   +18 more
europepmc   +1 more source

Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial.

JAMA Netw Open
Zhu J, Zhao C, Mi C, Liu S, Wu R, Li T, Duan X, Sun L, Yang L, He X, Liu W, Li Y, Ma L, Du H, Liu Y, Chen G, Zhang H, Wang T, Liu X, Shi X, Liu J, Wu H, Sun H, Xue Y, Chai K, Li H, Hu J, Dong F, Lin L, Du Q, Bai X, Huang F.   +31 more
europepmc   +1 more source

Assessing the diagnostic performance of the muscle biopsy features in the 2024 ENMC Inclusion Body Myositis Criteria. [PDF]

Rheumatology (Oxford)
Ekici M, Lilleker JB, Chinoy H.
europepmc   +1 more source

Reporting of Race and Ethnicity in SLE Studies in High-Impact Rheumatology Journals. [PDF]

Open Access Rheumatol
Eroglu I, Suter LG, Baker H.
europepmc   +1 more source

Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale). [PDF]

Rheumatol Int
Liakouli V, Forte G, Ruscitti P, Minerba M, Orlando A, Navarini L, Bellisai F, Caso F, Guggino G, Barbera L, Rizzo C, Corrado A, Triggianese P, Lo Gullo A, Mandraffino G, Cantarini L, Frediani B, Cipriani P, Cantatore FP, Chimenti MS, Favoino E, Perosa F, Iagnocco A, Giacomelli R, Ciccia F.   +24 more
europepmc   +1 more source

Low-energy small language models with retrieval-augmented generation can surpass large-model performance in rheumatology. [PDF]

Front Med (Lausanne)
Felde S, Buchkremer R, Chehab G, Thielscher C, Distler JHW, Schneider M, Richter JG.   +6 more
europepmc   +1 more source

Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study. [PDF]

J Immunother Cancer
Tison A, Jannat-Khah D, Cappelli LC, Suarez-Almazor ME, Abdel-Wahab N, Reid P, Sparks JA, Braaten TJ, Meara A, Calabrese C, Katsumoto T, Ghosh N, Ge K, Saraux A, Devauchelle-Pensec V, Shah AA, Bingham CO, Bass AR.   +17 more
europepmc   +1 more source

When Blood Proteins Reveal What Transcripts Miss: Immune Cell Priming and the Road to Prognostic Biomarkers in Lupus

Arthritis &Rheumatology, EarlyView.
Ioannis Parodis
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Rheumatology

JAMA: The Journal of the American Medical Association, 1995
In some populations, the presence and the dose of the "rheumatoid" epitope have been associated with severe rheumatoid arthritis. Newer treatments include oral antibiotics, oral type II collagen, and a number of biological products. Identification of a mutation in the type II procollagen genes is evidence that some clinical osteoarthritis is ...
G S, Alarcón, K V, Straaton
openaire   +2 more sources